Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001209191-14-067085
Filing Date
2014-11-06
Accepted
2014-11-06 18:07:46
Documents
2
Period of Report
2014-11-04

Document Format Files

Seq Description Document Type Size
1 FORM 3 SUBMISSION doc3.html 3  
1 FORM 3 SUBMISSION doc3.xml 3 3061
2 EX-24 DOCUMENT attachment1.htm EX-24 2644
  Complete submission text file 0001209191-14-067085.txt   7154
Mailing Address 200 - 3650 GILMORE WAY BURNABY A1 V5G 48W
Business Address 200 - 3650 GILMORE WAY BURNABY A1 V5G 48W (604) 484-3300
Xenon Pharmaceuticals Inc. (Issuer) CIK: 0001582313 (see all company filings)

EIN.: 980661854 | State of Incorp.: A1 | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address 5375 MEDPACE WAY CINCINNATI OH 45227
Business Address 5375 MEDPACE WAY CINCINNATI OH 45227 604-484-3300
MX Associates, LLP (Reporting) CIK: 0001624453 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-36687 | Film No.: 141202120